Alberto-Culver's Noxzema Quality Issues Traced To P&G Facility; Suit Filed
This article was originally published in The Rose Sheet
Executive Summary
A lawsuit filed by Alberto-Culver against Procter & Gamble - over the Noxzema brand each has parented - bears further testimony to quality control issues at P&G's manufacturing plant in Puerto Rico, which drew an FDA warning letter in April
You may also be interested in...
P&G Throws Weight Behind Consumer Growth After Shedding Pharma
Procter & Gamble washes its hands of prescription pharmaceuticals to focus on its consumer brands, though experts say the firm faces obstacles to growing its beauty and OTC portfolio
P&G Throws Weight Behind Consumer Growth After Shedding Pharma
Procter & Gamble washes its hands of prescription pharmaceuticals to focus on its consumer brands, though experts say the firm faces obstacles to growing its beauty and OTC portfolio
Evidence Of Bacterial Contamination At P&G Factory Draws Warning Letter
An FDA warning letter to Procter & Gamble directs the company to address evidence of bacterial contamination in its manufacturing plant in Cayey, Puerto Rico